Amgen’s Cannibalistic Ways

Amgen’s Cannibalistic Ways
If you don’t think that Amgen is excited about its future, check out what the company is piling on its plate. The biotech giant will be earmarking half of next year’s revenue to launch a $5 billion share buyback.


Leave a Reply

Your email address will not be published. Required fields are marked *